Lovenox With Aspirin in Thawed Blastocyst Transfer

Description

This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Conditions

Infertility, Female

Talk to us

Study Overview

On this page

Study Details

Study overview

This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Lovenox With Aspirin in Thawed Blastocyst Transfer

Lovenox With Aspirin in Thawed Blastocyst Transfer

Condition
Infertility, Female
Intervention / Treatment

-

Contacts and Locations

Las Vegas

Fertility center of Las Vegas, Las Vegas, Nevada, United States, 89117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Female patient 18-42 years of age with frozen embryos or oocytes seeking embryo transfer.
  • 2. Use of pre-implantation genetically tested (PGT) blastocysts is allowed but not required.
  • 3. Use of donated embryos or embryos derived from donated eggs is allowed.
  • 4. Prior history of successful, failed, and/or canceled IVF cycles are allowed.
  • 1. Minor (age\<18 years).
  • 2. Currently pregnant.
  • 3. Unable to provide informed consent in English.
  • 4. Gestational carrier or "surrogate".
  • 5. Blastocysts frozen at another center (Oocytes frozen elsewhere is acceptable).
  • 6. Subject intending or having "natural cycle" thaw transfer with an active ovarian follicle present.
  • 7. Currently participating in any other research study.
  • 8. Subject already had an embryo transfer under this study.
  • 9. History of thrombocytopenia (reduced platelets), bleeding disorders, or routinely using anti-coagulant medication.
  • 10. Hypersensitivity to aspirin, heparin, or benzyl alcohol.
  • 11. Anyone for whom the physician assesses this protocol is inappropriate or unsafe.

Ages Eligible for Study

18 Years to 42 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Fertility Center of Las Vegas,

Bruce Shapiro, MD, PhD, PRINCIPAL_INVESTIGATOR, Fertility Center of Las Vegas

Study Record Dates

2024-12-15